Ugarte A, De la Mora L, Martinez-Rebollar M, Mallolas J, et al. An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide-induced cholestasis. Antivir Ther 2021;26.
PMID: 35485342